Merck Tbk. vs Multi Hanna Kreasindo Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Multi Hanna Kreasindo Tbk. trades at Rp137 (market cap 510B, 7.95M 24h volume). The key difference: Merck Tbk. is far larger — about 3.3× Multi Hanna Kreasindo Tbk.'s market cap, and Multi Hanna Kreasindo Tbk. is more actively traded (7.95M versus 37.6K). Which is the better fit depends on your goals.
| MERK | MHKI | |
|---|---|---|
Market Cap | 1.7T | 510B |
Volume | 37.6K | 7.95M |
Lot | 376 | 79.48K |
Turnover | 144.47M | 1.1B |
Average Price | 3,842.23 | 138.19 |
Value | 144.47M | 1.1B |
Indicative Equilibrium Price | 3,840 | 137 |
Indicative Equilibrium Volume | 7 | 911 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.
Read more on MHKI →